Lunch with Liucci: Billy Liucci joins TexAgs Live (Friday, June 19)

TexAgs' co-owner and executive editor Billy Liucci joined TexAgs Live on Friday morning to chat about the commitment of five-star linebacker Kaden Henderson and the recruiting momentum from the volleyball and baseball programs.
Lunch with Liucci
By Billy Liucci
June 19, 2026
9.6k Views
2 Comments
Story Poster
Photo by @selfmadekadenn/Instagram
Free Preview
Watch the full version by becoming a Premium subscriber.
Try Premium for $1
No Thanks
Trial available for new subscribers only.

Segment 1 (00:00:00 - 16:53:21)

  • Kaden Henderson‍ had been trending toward Texas A&M for a while in this recruitment. Most times, when you feel really good about a guy, you get him to commit, but not all the time. Notre Dame couldn't be ignored. In the last four to five days, it's really shifted in A&M’s favor. 
     
  • He is a five-star linebacker. He is a prospect that everyone in the country wanted. This is a big one for the Aggies.
To view this content, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits →
Trial only available to users who have never subscribed or participated in a previous trial
2 Comments
Tags
TexAgs Live Richard Zane David Nuño 12th Man Foundation TexAgs Live Feature Jimbo Fisher Lunch with Liucci Transfer Portal Edgerrin Cooper Walter Nolen Shemar Stewart LT Overton
Show All
Wade Cooper Maya Ogbogu Kevin Minter Kaden Henderson Football Recruiting Volleyball Baseball Recruiting Texas A&M 2027
SPONSORED BY
12th Man Foundation
More Episodes
See All →
Lunch with Liucci: Billy Liucci joins TexAgs Live (Friday, September 11)
By Billy Liucci
Lunch with Liucci: Billy Liucci joins TexAgs Live (Monday, September 7)
By Billy Liucci
Lunch with Liucci: Billy Liucci joins TexAgs Live (Friday, September 4)
By Billy Liucci
Lunch with Liucci: Billy Liucci joins TexAgs Live (Monday, August 31)
By Billy Liucci
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.